Home / Events /

Almac Clinical Technologies is delighted to be attending The Disruptive Technology for Clinical Trials 2026 conference, taking place on the 27th January in London, UK.

About Disruptive Technology for Clinical Trials 2026

This interactive forum focuses on advancing decentralised clinical trials. Attendees will explore innovations such as remote monitoring, wearables, AI, and digital solutions like e-PRO and eConsent to enhance patient experience, improve recruitment, and ensure long-term success through measurable technology integration.

For more information and to register for the event, please visit the Disruptive Technology for Clinical Trials website.

Share this event

Share on Facebook Share on Twitter Share on LinkedIn
Mike Hutton

Mike Hutton

Director | Strategic Partnerships and Commercialization | Almac Clinical Technologies

Email

Director | Strategic Partnerships and Commercialization | Almac Clinical Technologies

Stay up-to-date with the latest from Almac

Join our mailing list
This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies